LITTLE KNOWN FACTS ABOUT ABBV-744 AS A POTENTIAL THERAPEUTIC OPTION FOR AGGRESSIVE CANCERS.

More studies in progress advise that ARV-825 may additionally be effective in improving the response to estrogen deprivation (aromatase inhibition), another part of normal of care in ER+ breast cancer.- "Our study revealed the crucial function from the KLF16/MYC regulatory axis in modulating tumor development and chemotherapy sensitivity in BLCA, s